Total payments PY{stats.data_year}
$13.3B
16,146,544 transactions
$13.3B in pharma payments to 983,926 doctors and 876 teaching hospitals — drawn from CMS Open Payments Program Year 2024, searchable by company, state, and payment type.
Clean, aggregated views of $13.3B in 2024 pharma payments to doctors & hospitals by company, state, type, and top recipients.
Explore $13.3B paid by 1,797 pharmaceutical companies to physicians and teaching hospitals — powered by CMS Open Payments data (Program Year 2024).
Total Payments
$13.3B
Program Year 2024
Companies
1,797
Pharma & device makers
Physicians
983,926
Receiving payments
Transactions
16,146,544
Individual payments
| # | Company | Total Payments | Transactions | % of Total |
|---|---|---|---|---|
| 1 | NOVARTIS PHARMACEUTICALS CORPORATION | $672.4M | 418,002 | 5.1% |
| 2 | PFIZER INC. | $668.7M | 604,338 | 5.0% |
| 3 | MODERNATX, INC. | $665.2M | 31,544 | 5.0% |
| 4 | ELI LILLY AND COMPANY | $649.6M | 18,711 | 4.9% |
| 5 | ABBVIE INC. | $604.3M | 1,765,388 | 4.5% |
| 6 | MERCK SHARP & DOHME LLC | $519.2M | 223,087 | 3.9% |
| 7 | ASTRAZENECA PHARMACEUTICALS LP | $408.7M | 614,737 | 3.1% |
| 8 | GENENTECH, INC. | $400.3M | 36,395 | 3.0% |
| 9 | MIDMARK CORPORATION | $386.1M | 381 | 2.9% |
| 10 | JANSSEN RESEARCH & DEVELOPMENT, LLC | $345.0M | 40,202 | 2.6% |
| # | State | Total Payments | Physicians | Hospitals |
|---|---|---|---|---|
| 1 | California | $334.5M | 71,271 | 104 |
| 2 | Florida | $304.7M | 52,615 | 64 |
| 3 | Pennsylvania | $303.3M | 30,506 | 48 |
| 4 | Massachusetts | $225.1M | 14,642 | 29 |
| 5 | Texas | $221.2M | 56,888 | 65 |
| 6 | New York | $211.9M | 47,420 | 85 |
| 7 | Missouri | $120.1M | 14,235 | 20 |
| 8 | Illinois | $118.0M | 28,020 | 46 |
| 9 | Ohio | $109.3M | 26,588 | 44 |
| 10 | Michigan | $100.2M | 22,991 | 37 |
Total payments PY{stats.data_year}
$13.3B
16,146,544 transactions
Physicians paid
983,926
876 teaching hospitals
$846.8M of $13.3B (6.4%)
Educational guides on the Sunshine Act, payment types, and how transparency data can inform your healthcare decisions.
What the Sunshine Act requires and how CMS collects payment data.
Research, consulting, speaking, and food payments — what each means.
What research shows about payments and prescribing patterns.
$13.3B in PY2024 — breakdown by category, trends, and top companies.
Speaker bureaus, consulting fees, advisory boards — how pharma shapes prescribing.
Browse 1,797 pharmaceutical and device companies by total payments.
View payments to physicians and hospitals by state.
See how payments break down: consulting, food, research, gifts, and more.
See the highest-paid physicians and teaching hospitals in America.
PlainPharmaWatch provides CMS Open Payments data showing pharmaceutical company payments to doctors, covering 6,000+ companies and totaling $13.3 billion in payment year 2024.
Payments include consulting fees, speaking fees, travel, meals, research grants, and ownership interests. Each payment is categorized by type and amount.
All data comes from the CMS Open Payments program, which requires drug and device manufacturers to publicly report payments made to physicians and teaching hospitals.
Every page renders directly from the current CMS Open Payments database — no curated narrative layer that could drift from the underlying dataset. See methodology.
Per-company total payments, transaction counts, and recipient coverage across all reporting applicable manufacturers in the CMS Open Payments database.
Live DataHighest-paid teaching hospitals, physicians, and other covered recipients from the current Program Year dataset.
Live DataAggregated totals by Nature of Payment category — consulting fees, food and beverage, royalties, and education.